Back to Search Start Over

Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.

Authors :
Cingolani A
Tummolo AM
Montemurro G
Gremese E
Larosa L
Cipriani MC
Pasciuto G
Liperoti R
Murri R
Pirronti T
Cauda R
Fantoni M
Source :
Infection [Infection] 2020 Oct; Vol. 48 (5), pp. 767-771. Date of Electronic Publication: 2020 Jul 08.
Publication Year :
2020

Abstract

A patient with COVID-19-related severe respiratory failure, with insufficient response to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt resolution of the respiratory function and improvement in the radiological picture after baricitinib at an oral dose of 4 mg per day for 2 weeks.

Details

Language :
English
ISSN :
1439-0973
Volume :
48
Issue :
5
Database :
MEDLINE
Journal :
Infection
Publication Type :
Academic Journal
Accession number :
32642806
Full Text :
https://doi.org/10.1007/s15010-020-01476-7